Hidenori Ando

アンドウヒデノリ | Hidenori Ando

Affiliation and department：

Research field (3)： Clinical pharmacy , Clinical pharmacy , Clinical pharmacy

Research keywords (6)：がん治療 , 抗がん剤 , エキソソーム , 核酸医薬 , リポソーム , ドラッグデリバリーシステム

Research theme for competitive and other funds (11)：

2023 - 2027 イオン液体を用いた中分子医薬品の革新的・非侵襲的吸収促進技術の開発
2023 - 2027 人工高分子PEGに対する生体防御反応の解明と統合的理解
2021 - 2024 高活性抗体の誘導を実現する抗原発現エキソソームの脾臓免疫技術基盤の構築
2020 - 2022 Enhanced absorption drug delivery system by ionic liquid
2019 - 2022 PEG修飾タンパクによるアナフィラキシー誘導機構の解明とその制御に関する研究

Show all

Papers (95)：

Eiichiro Kaneko, Haruto Tsujisaki, Masashi Fujiwara, Hidenori Ando, Yasushi Sato, Tatsuhiro Ishida, Hirofumi Tani, Kenji Tajima. Application of bacterial-derived long cellulose nanofiber to suspension culture of mammalian cells as a shear protectant. International Journal of Biological Macromolecules. 2024. 135938-135938
Taiki Hori, Taro Shimizu, Hidenori Ando, Naoto Okada, Hiroki Yamagami, Saya Yasui, Minae Hosoki, Akihiro Tojima, Toshiki Otoda, Tomoyuki Yuasa, et al. Humoral immune response against SARS-CoV-2 and polyethylene glycol elicited by anti-SARS-CoV-2 mRNA vaccine, and effect of pre-existing anti-polyethylene glycol antibody in patients with hematological and autoimmune diseases. Heliyon. 2024. 10. 10. e31489-e31489
松尾アモリムクリスティーナ菜々, 安藤英紀, 田島健次, 高田春風, 松島得雄, 草野貴友, 石田竜弘. 細菌由来ナノセルロースの経口摂取による腸内細菌叢調節が食事性肥満モデルマウスの体重増加に与える影響の評価. 日本栄養・食糧学会大会講演要旨集. 2024. 78回. 257-257
Sherif A Gaballa, Shimizu Taro, Takata Haruka, ANDO Hidenori, Mohamed Ibrahim, Sherif Emam Abdallah Emam, Matsuo Amorim Cristina Nana, Kim Yuri, Youssef W Naguib, Fatma M Mady, et al. Impact of anti-PEG IgM induced via the topical application of a cosmetic product containing PEG derivatives on the antitumor effects of PEGylated liposomal antitumor drug formulations in mice. Molecular Pharmaceutics. 2024. Vol.21. No.2. 622-632
Taro Shimizu, Amr S Abu Lila, Yuka Kitayama, Ryo Abe, Haruka Takata, Hidenori Ando, Yu Ishima, Tatsuhiro Ishida. Peritoneal B Cells Play a Role in the Production of Anti-polyethylene Glycol (PEG) IgM against Intravenously Injected siRNA-PEGylated Liposome Complexes. Biological & pharmaceutical bulletin. 2024. 47. 2. 469-477

ｍore...

MISC (20)：

Gaballa Sherif A, Shimizu Taro, ANDO Hidenori, Takata Haruka, Emam Abdallah Emam Sherif, Abdelhameed Mostafa Ramadan Eslam, Naguib Youssef W, Mady Fatma M, Khaled Khaled A, Ishida Tatsuhiro. Treatment-induced and pre-existing anti-PEG antibodies: Prevalence, clinical implications, and future perspectives. Journal of Pharmaceutical Sciences. 2024. Vol.113. No.3. 555-578
金子瑛一郎, 辻崎晴人, 藤原政司, 谷博文, 田島健次, 安藤英紀, 石田竜弘. Suppression of mechanical stress in suspension culture of mammalian cell by nanofibrillated bacterial cellulose. セルロース学会年次大会講演要旨集. 2023. 30th
松尾アモリムクリスティーナ奈々, 安藤英紀, 田島健次, 松島得雄, 草野貴友, 石田竜弘. Preparation of spheroids with HepG2 cells using nanofibrillated bacterial cellulose and evaluation of its drug metabolism. セルロース学会年次大会講演要旨集. 2023. 30th
Mohamed Ibrahim, Abdelhameed Mostafa Ramadan Eslam, Elhewan Ali Emam Elsadek Emam Nehal, Emam Abdallah Emam Sherif, Shimizu Taro, ANDO Hidenori, Ishima Yu, Omar Helmy Elgarhy, Hatem A Sarhan, Amal K Hussein, et al. Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products. Journal of Controlled Release. 2022. Vol.351. 215-230
Nana Cristina Amorim Matsuo, Hidenori Ando, Yusuke Doi, Taro Shimizu, Yu Ishima, Tatsuhiro Ishida. The Challenge to Deliver Oxaliplatin (l-OHP) to Solid Tumors: Development of Liposomal l-OHP Formulations. Chemical & pharmaceutical bulletin. 2022. 70. 5. 351-358

ｍore...

Books (2)：

ナノフィブリル化バクテリアセルロースの生産とその応用
NTS Inc. 2021
ドラッグデリバリーシステム(DDS)
京都廣川書店 2015

Lectures and oral presentations (297)：

Protein-bound cisplatin can induce therapeutic action for cisplatin with lessening its adverse events
(APSTJ Global Education Seminar 2024 2024)
HPLC/ICP-MS測定系を用いたシスプラチンのタンパク結合解析とタンパク結合形シスプラチンが副作用および抗腫瘍効果に与える影響の評価
(第45回生体膜と薬物の相互作用シンポジウム 2024)
イオン液体による中分子化合物の経口吸収促進機構の解明;消化管密着結合及び消化管吸収部位への影響
(第45回生体膜と薬物の相互作用シンポジウム 2024)
mRNA搭載脂質ナノ粒子に修飾されたPEGに対する免疫応答に脾臓および胸腺が与える影響
(第45回生体膜と薬物の相互作用シンポジウム 2024)
脾臓辺縁帯B細胞標的化リポソームをSLEモデルマウス・MRL/lprマウスに投与した際の標的化能力低下の原因究明
(第45回生体膜と薬物の相互作用シンポジウム 2024)

ｍore...

Education (3)：

2011 - 2014 University of Shizuoka School of Pharmaceutical Sciences Department of Medical Biochemistry
2009 - 2011 University of Shizuoka School of Pharmaceutical Sciences
2005 - 2009 University of Shizuoka School of Pharmaceutical Sciences Pharmaceutical Sciences

Professional career (1)：

薬学博士 (静岡県立大学)

Work history (5)：

2023/04 - 現在 Tokushima University Institute of Biomedical Sciences Associate Professor
2018/03 - 2023/03 Tokushima University Institute of Biomedical Sciences Project Assistant Professor
2017/04 - 2018/02 Yamaguchi University School of Medicine Assistant Professor
2015/04 - 2017/03 Tokushima University Institute of Biomedical Sciences Project Assistant Professor
2014/04 - 2015/03 Tokushima University Institute of Health Biosciences Project Assistant Professor

Awards (8)：

2023/05/17 - 日本薬剤学会 2023年度日本薬剤学会奨励賞腹膜播種治療を目指した臨床応用可能な腹腔内投与型核酸医薬製剤の開発
2023/03/13 - Tokushima University 大学院医歯薬学研究部長表彰
2022/12/15 - Tokushima University 徳島大学若手研究者学長表彰
2022/06/30 - 日本DDS学会第14回日本DDS学会奨励賞脾臓標的DDS技術を利用して刷新的な抗体を誘導する新規免疫技術の開発
2020/12/07 - 日本薬学会中国四国支部奨励賞 DDS抗がん剤の腫瘍内局在の解明と腫瘍微小環境改善による効果増強

Show all

Association Membership(s) (7)：

Controlled Release Society , THE JAPANESE SOCIETY FOR IMMUNOLOGY , THE SOCIETY OF POLYMER SCIENCE, JAPAN , THE CELLULOSE SOCIETY OF JAPAN , THE ACADEMY OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, JAPAN , THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM , THE PHARMACEUTICAL SOCIETY OF JAPAN

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page